The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...
Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...
An echocardiogram, or echo, is a heart ultrasound. It uses sound waves to create an image of the heart. Doctors can use this image to diagnose heart failure, as well as assess whether heart failure ...
Cardiovascular diseases, the leading global cause of mortality, are frequently driven by hypertension, which contributes to left ventricular hypertrophy (LVH) and heart failure. Although ejection ...
Hemodynamic force analysis has been proposed as a novel tool for early detection of subclinical systolic dysfunction in heart failure with preserved ejection fraction (HFpEF). Here we investigated the ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
In contrast to the advances in therapy for systolic HF over the past three decades, which have improved mortality rates, no therapies have been proven to reduce mortality in patients with HFNEF (Table ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results